Research Advance of Chinese Medicine in Treating Atherosclerosis: Focus on Lipoprotein-Associated Phospholipase A2

被引：2
|
作者：
Wang, Lu-ming [1 ]
Zhang, Wen-lan [1 ]
Lyu, Nuan [1 ]
Suo, Yan-rong [2 ]
Yang, Lin [1 ]
Yu, Bin [3 ]
Jiang, Xi-juan [1 ]
机构：
[1] Tianjin Univ Tradit Chinese Med, Sch Integrat Med, Tianjin 301617, Peoples R China
[2] Ganzhou Peoples Hosp, Dept Tradit Chinese Med, Ganzhou 341000, Jiangxi, Peoples R China
[3] Tianjin Univ Tradit Chinese Med, Sch Med Technol, Tianjin 301617, Peoples R China
来源：
CHINESE JOURNAL OF INTEGRATIVE MEDICINE | 2024年 / 30卷 / 03期
基金：
中国国家自然科学基金;
关键词：
lipoprotein-associated phospholipase A2; atherosclerosis; inflammation; oxidative stress; apoptosis; Chinese medicine; PLATELET-ACTIVATING-FACTOR; OXYGEN SPECIES PRODUCTION; RHO-KINASE; MACROPHAGE APOPTOSIS; A(2) EXPRESSION; LYSOPHOSPHATIDYLCHOLINE; RESVERATROL; INFLAMMATION; INHIBITION; LP-PLA(2);
D O I：
10.1007/s11655-023-3611-6
中图分类号：
R [医药、卫生];
学科分类号：
10 ;
摘要：
As a serious cardiovascular disease, atherosclerosis (AS) causes chronic inflammation and oxidative stress in the body and poses a threat to human health. Lipoprotein-associated phospholipase A2 (Lp-PLA2) is a member of the phospholipase A2 (PLA2) family, and its elevated levels have been shown to contribute to AS. Lp-PLA2 is closely related to a variety of lipoproteins, and its role in promoting inflammatory responses and oxidative stress in AS is mainly achieved by hydrolyzing oxidized phosphatidylcholine (oxPC) to produce lysophosphatidylcholine (lysoPC). Moreover, macrophage apoptosis within plaque is promoted by localized Lp-PLA2 which also promotes plaque instability. This paper reviews those researches of Chinese medicine in treating AS via reducing Lp-PLA2 levels to guide future experimental studies and clinical applications related to AS.
引用
收藏
页码：277 / 288
页数：12
相关论文
共 50 条
  • [31] Plasma Lipoprotein-associated Phospholipase A2 in Patients with Metabolic Syndrome and Carotid Atherosclerosis
    Hui-ping Gong
    Yi-meng Du
    Li-na Zhong
    Zhao-qiang Dong
    Xin Wang
    Yong-jun Mao
    Qing-hua Lu
    Lipids in Health and Disease, 10
  • [32] The Role of Lipoprotein-Associated Phospholipase A2 as a Marker and Potential Therapeutic Target in Atherosclerosis
    Ralph A. H. Stewart
    Harvey D. White
    Current Atherosclerosis Reports, 2011, 13 : 132 - 137
  • [33] Role of lipoprotein-associated phospholipase A2 in atherosclerosis and its potential as a therapeutic target
    Macphee, CH
    Nelson, J
    Zalewski, A
    CURRENT OPINION IN PHARMACOLOGY, 2006, 6 (02) : 154 - 161
  • [34] The Role of Lipoprotein-Associated Phospholipase A2 as a Marker and Potential Therapeutic Target in Atherosclerosis
    Stewart, Ralph A. H.
    White, Harvey D.
    CURRENT ATHEROSCLEROSIS REPORTS, 2011, 13 (02) : 132 - 137
  • [35] Lipoprotein-associated phospholipase A2: The story continues
    Huang, Fubao
    Wang, Kai
    Shen, Jianhua
    MEDICINAL RESEARCH REVIEWS, 2020, 40 (01) : 79 - 134
  • [36] Lipoprotein-associated phospholipase A2 is associated with the risk of dementia
    van Oijen, M
    van der Meer, IM
    Hofman, A
    Witteman, JCM
    Koudstaal, PPJ
    Breteler, MMB
    NEUROLOGY, 2005, 64 (06) : A268 - A268
  • [37] Variability of lipoprotein-associated phospholipase A2 measurements
    McConnell, Joseph P.
    Jaffe, Allan S.
    CLINICAL CHEMISTRY, 2008, 54 (05) : 932 - 933
  • [38] Lipoprotein-associated phospholipase A2 is associated with risk of dementia
    van Oijen, M
    van der Meer, IM
    Hofman, A
    Witteman, JCM
    Koudstaal, PJ
    Breteler, MMB
    ANNALS OF NEUROLOGY, 2006, 59 (01) : 139 - 144
  • [39] Lipoprotein and Lipoprotein-associated Phospholipase A2 as Atherosclerosis Risk Factors (oxLDL) in Men with Central Obesity
    Sari, Nelly
    Wijaya, Andi
    Patellongi, Ilhamjaya
    INDONESIAN BIOMEDICAL JOURNAL, 2011, 3 (01): : 51 - 56
  • [40] The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma
    Tellis, Constantinos C.
    Tselepis, Alexandros D.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2009, 1791 (05): : 327 - 338
12345